Notice of Refund | Dec 9, 2015 | PAPER | BOARD |
Refund Request | Dec 8, 2015 | PAPER | PETITIONER |
Decision - Granting Petitioner's Motion to Withdraw Its Request for Rehearing - 37 CFR 42.71 | Oct 5, 2015 | PAPER | BOARD |
Motion to Withdraw Request for Rehearing | Oct 2, 2015 | PAPER | PETITIONER |
Request for Rehearing | Aug 12, 2015 | PAPER | PETITIONER |
Decision Denying Institution of Inter Partes Review | Jul 13, 2015 | PAPER | BOARD |
PATENT OWNERS UPDATED MANDATORY NOTICES PURSUANT TO 37 C.F.R. 42.8 | May 11, 2015 | PAPER | PATENT OWNER |
Patent Owner Preliminary Response | Apr 15, 2015 | PAPER | PATENT OWNER |
Patent Owner Exhibit List | Apr 15, 2015 | PAPER | PATENT OWNER |
Beutler et al., Williams Hematology, Fifth Edition (1995) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Macgrath, Ian T., The Non-Hodgkins Lymphomas, Second Edition (1997) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Wiernik et al., Neoplastic Diseases of the Blood, Third Edition (1996) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Rituxan (Rituximab) Labeling Text (February 2006) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Office Restriction Requirement dated Oct. 15, 2009 | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Applicants Election dated Jan. 29, 2010 | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Information Disclosure Statement | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
P.S. Multani and M. Grossbard, Monoclonal Antibody-Based Therapies for Hematologic Malignancies, J. Clinical Oncology 16_3691-3710 (1998) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Applicants Remarks/Arguments dated June 6, 2011 | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Rituxan Product Label (September 2006) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Archived ECOG website pulled from the Internet Archive | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
UCLA Medical Library copy of Ex. 1052 | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Guidelines | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Rohatiner et al., Meta-Analysis to Evaluate the Role of Interferon in Follicular Lymphoma, J. Clinical Oncology, Vol. 23, No. 10 (April 1, 2005) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
FDA Draft Guidance for Industry, Distributing Scientific and Medical Publications on Unapproved New Uses - Recommended Practices, February 2014 | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Combination Chemotherapy With or Without Monoclonal Antibody | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Solal-Celigny et al., Non-Hodgkins Lymphomas (1993) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Schein et al., Non-Hodgkins Lymphoma - patterns of Relapse from Complete Remission After Combination Chemotherapy, Cancer 35_354-357 (1975) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Cabanillas et al., Clinical, Biologic, and Histologic Features of Late Relapses in Diffuse Large Cell Lymphoma, Blood, Vol. 79, No. 4 (February 15, 1992) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Davis, Levy, Therapy of B Cell Lymphoma with anti-CD20 antibodies can result in relapse with loss of CD20 Expression, Proceedings of the American Association for Cancer Research, Vol. 39 (March 1998) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Carlson, Robert, Rituximab plus CHOP - a new approach for non-Hodgkins lymphoma, Inpharma No. 1116 (Dec. 6, 1997) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Blackwelder, William, Proving the Null Hypothesis In Clinical Trials, Controlled Clinical Trials 3_345-353 (1982) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Gail A. Leget, Myron S. Czuczman, Use of rituximab, the new FDA-approved antibody, Oncology 10_548-551 (1998) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Dana_A Randomized Study Of Alpha-Interferon Consolidation In Patients With Low-Grade Lymphoma Who Have Responded To Pro-Mace-Mopp (Day 1-8) (SWOG 8809), Proceedings of ASCO Vol. 16, 48 (1997) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Peterson et al., Cyclophosphamide versus Cyclophosphamide Plus Interferon Alfa-2b In Follicular Low Grade Lymphomas_An Intergroup Phase III Trial (CALGB 8691 and EST 7486), Proceedings of ASCO Vol. 16, 48 (1997) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Chisesi et al., Randomized Study of Chlorambucil (CB) Compared to Interferon (Alfa-2b) Combined with CB in Low-Grade Non-Hodgkins Lymphoma_An interim report of a randomized study, Eur F Cancer, Vol. 27, Suppl. 4, pp.S31-S33 (1991) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Grossbard, Michael, American Cancer Society Atlas Of Clinical Oncology Malignant Lymphomas (2002) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Unterhalt_Long Term Interferon Alpha Maintenance Prolongs Remission Duration In Advanced Low Grade Lymphomas And Is Related To The Efficacy Of Initial Cytoreductive Chemotherapy, Blood, Journal of the American Society of Hematology (December 6-10, 1996) | Apr 15, 2015 | EXHIBIT | PATENT OWNER |
Unopposed Motion for Pro Hac Vice Admission of David Gindler | Apr 2, 2015 | PAPER | PATENT OWNER |
Patent Owner Power of Attorney and Notice of Appearance of Additional Counsel | Mar 9, 2015 | PAPER | PATENT OWNER |
Power of Attorney | Jan 23, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Power of Attorney | Jan 23, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Power of Attorney | Jan 20, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Related Matters | Jan 20, 2015 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Notice of Filing Date Accorded to Petition | Jan 15, 2015 | PAPER | BOARD |
Power of Attorney | Dec 15, 2014 | PAPER | PETITIONER |
Power of Attorney | Dec 15, 2014 | PAPER | PETITIONER |
Petition for IPR of US Patent 8329172 | Dec 15, 2014 | PAPER | PETITIONER |
Ex 1001 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1002 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1003 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1004 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1005 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1006 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1007 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1008 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1009 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1010 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1011 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1012 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1013 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1014 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1015 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1016 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1017 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1018 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1019 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1020 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1021 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1022 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1023 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1024 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1025 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1026 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1027 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1028 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1029 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1030 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1031 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1032 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1033 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1034 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1035 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1036 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1037 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1038 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1039 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1040 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1041 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1042 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1043 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1044 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1045 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1046 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1047 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1048 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1049 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1050 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1051 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1052 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1053 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1054 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1055 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1056 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1057 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1058 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1059 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1060 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1061 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1062 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1063 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1064 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1065 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1066 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1067 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1068 | Dec 15, 2014 | EXHIBIT | PETITIONER |
Ex 1069 | Dec 15, 2014 | EXHIBIT | PETITIONER |